Table 1 Baseline characteristics of the CARLA study population (2002–2006): distribution of cardiovascular risk factors and diseases
Women | Men | |||||
|---|---|---|---|---|---|---|
N | Median | Min; Q1; Q3; Max | N | Median | Min; Q1; Q3; Max | |
Age (years) | 812 | 63.3 | 45.8; 54.9; 71.8; 83.4 | 967 | 64.9 | 45.4; 55.8; 74.0; 83.3 |
SBP (mmHg) | 812 | 138.0 | 89.0; 125.5; 155.0; 231.0 | 966 | 145.5 | 93.0; 131.5; 158.5; 227.0 |
DBP (mmHg) | 812 | 82.5 | 54.0; 76.0; 90.0; 122.0 | 966 | 85.5 | 52.5; 78.5; 93.0; 127.0 |
Heart rate (1/min) | 778 | 67.0 | 39.4; 60.9; 73.4; 105.4 | 893 | 65.7 | 43.9; 60.2; 74.7; 112.4 |
Total cholesterol (mmol/l) | 807 | 5.7 | 1.4; 5.0; 6.4; 10.7 | 960 | 5.3 | 2.1; 4.9;5.9; 17.8 |
HDL cholesterol (mmol/l) | 807 | 1.5 | 0.4; 1.3; 1.8; 3.4 | 960 | 1.2 | 0.3; 1.0;1.5; 3.0 |
LDL cholesterol (mmol/l) | 801 | 3.4 | 0.9; 2.8; 4.0; 7.3 | 940 | 3.1 | 0.9; 2.6;3.7; 7.2 |
Cholesterol/HDL ratio | 807 | 3.8 | 1.7; 3.0; 4.5; 9.7 | 960 | 4.3 | 1.7; 3.5; 5.2; 13.0 |
Triglycerides (mmol/l) | 807 | 1.4 | 0.2; 1.0; 1.9; 11.6 | 960 | 1.7 | 0.4; 1.2;2.5; 38.2 |
Glucose (mmol/l) | 807 | 5.4 | 3.1; 5.1; 5.9; 19.8 | 960 | 5.6 | 3.0; 5.2;6.3; 21.5 |
HbA1c (%) | 807 | 5.6 | 3.1; 5.3;5.9; 12.0 | 960 | 5.6 | 2.8; 5.3;6.0; 11.7 |
Body mass index (kg/m2) | 812 | 28.0 | 18.1; 24.7; 31.5; 53.7 | 967 | 27.7 | 16.5; 25.4;30.8; 43.3 |
Waist hip ratio | 812 | 0.9 | 0.7; 0.8; 0.9; 1.2 | 967 | 1.0 | 0.8; 1.0; 1.0; 1.2 |
For current smokers: pack-years | 119 | 19.5 | 0.2; 10.6; 26.6; 61.0 | 225 | 29.0 | 0.5; 18.0; 38.4; 85.1 |
Alcohol consumption gram/day | 812 | 0 | 0; 0; 5.0; 60.5 | 964 | 12.5 | 0; 2.5; 26.2; 113.6 |
N | Proportion | 95% CI | N | Proportion | 95% CI | |
Smoking | 812 | 966 | ||||
Current | 119 | 14.7 | 12.2–17.1 | 225 | 23.3 | 20.6–26.0 |
Past | 140 | 17.2 | 14.6–19.8 | 496 | 51.3 | 48.2–54.5 |
Never | 553 | 68.1 | 64.9–71.3 | 245 | 25.4 | 22.6–28.1 |
Sports: physically active | 347 | 42.8 | 39.4–46.2 | 296 | 30.6 | 27.7–33.6 |
Education yearsa | 812 | 967 | ||||
≤10 | 121 | 14.9 | 12.4–17.4 | 36 | 3.7 | 2.5–4.9 |
11–13 | 388 | 47.8 | 44.3–51.2 | 391 | 40.4 | 37.3–43.5 |
14–17 | 231 | 28.4 | 25.3–31.6 | 335 | 34.6 | 31.6–37.6 |
≥18 | 72 | 8.9 | 6.9–10.8 | 205 | 21.2 | 18.6–23.8 |
Drug use | ||||||
Beta-blockers | 279 | 34.4 | 31.1–37.6 | 307 | 31.7 | 28.8–34.7 |
Anti-arrhythmics | 5 | 0.6 | 0.1–1.2 | 8 | 0.8 | 0.3–1.4 |
ACE-inhibitors | 254 | 31.3 | 28.1–34.5 | 340 | 35.2 | 32.1–38.2 |
Diuretics | 80 | 9.9 | 7.8–11.9 | 104 | 10.8 | 8.8–12.7 |
Ca-channel blockers | 123 | 15.1 | 12.7–17.6 | 148 | 15.3 | 13.0–17.6 |
Disease prevalence | ||||||
Myocardial infarction | 20 | 2.4 | 0.8–3.7 | 50 | 5.2 | 2.7–7.6 |
Stroke | 27 | 3.3 | 2.1–4.6 | 42 | 4.3 | 3.1–5.6 |
Cardiovascular diseaseb | 48 | 5.9 | 4.3–7.5 | 153 | 15.8 | 13.5–18.1 |
Hypertensionc | 611 | 75.2 | 72.3–78.2 | 794 | 82.1 | 79.7–84.5 |
Diabetes mellitusd | 120 | 14.8 | 12.3–17.2 | 154 | 15.9 | 13.6–18.3 |